Select your country

20.10.2020
STADA Fact of the Month
STADA Fact of the Month

STADA Health Report on World Osteoporosis Day 2020: Europeans know too little about bone disease

Read more

13.10.2020
Enyzmatica and STADA extend agreement on ViruProtect
Enyzmatica and STADA extend agreement on ViruProtect

To Russia, Poland, Ukraine and CIS countries

Read more

02.10.2020
STADA expands specialty footprint
STADA expands specialty footprint

Acquisition of innovative therapy for treating advanced Parkinson’s disease

Read more

14.09.2020
Romaniszyn leads STADA Poland’s growth strategy
Romaniszyn leads STADA Poland’s growth strategy

Paulina Romaniszyn joins STADA as country head, Poland.

Read more

10.09.2020
STADA Health Report on World Contraception Day 2020
STADA Health Report on World Contraception Day 2020

World Contraception Day on September 26 to raise awareness

Read more

25.08.2020
Anders Fogstrup becomes new General Manager of STADAPHARM
Anders Fogstrup becomes new General Manager of STADAPHARM

Fogstrup will take over management of STADAPHARM from September 1, 2020.

Read more

07.08.2020
Nidda Healthcare GmbH sets cash compensation for transfer of shares
Nidda Healthcare GmbH sets cash compensation for transfer of shares

Nidda Healthcare GmbH sets cash compensation for the transfer of the shares of the minority shareholders of STADA Arzneimittel AG at 98.51 E…

Read more

31.07.2020
STADA Friday Fact
STADA Friday Fact

Look into the future: “Polypill” divides Europe

Read more

29.07.2020
STADA Health Report 2020:
STADA Health Report 2020:

One in five Europeans expects rapid return to normal

Read more

01.07.2020
New name – proven strengths
New name – proven strengths

STADA GmbH becomes STADA Consumer Health Deutschland GmbH

Read more

17.06.2020
STADA Health Report 2020
STADA Health Report 2020

Europe demands compulsory vaccinations

Read more

08.06.2020
Nidda Healthcare GmbH intends to conduct a squeeze-out
Nidda Healthcare GmbH intends to conduct a squeeze-out

Squeeze-out of minority shareholders in STADA Arzneimittel AG under stock corporation law

Read more

06.05.2020
Bausch + Lomb licenses exclusive rights from STADA and Xbrane
Bausch + Lomb licenses exclusive rights from STADA and Xbrane

To a biosimilar candidate for Lucentis (ranibizumab) in the United States and Canada

Read more

20.04.2020
Corona Survey
Corona Survey

Insights into how people in four major European countries are feeling about healthcare issues amid the COVID-19 crises.

Read more

09.04.2020
STADA responds to urgent need by making more medicines than ever
STADA responds to urgent need by making more medicines than ever

March 2020 saw the highest production output in STADA’s 125-year history as the COVID-19 crisis significantly raised demand for critical med…

Read more

05.03.2020
STADA closes acquisition of Walmark
STADA closes acquisition of Walmark

Creating a winning portfolio for Central Europe

Read more

04.03.2020
STADA takes clear lead in Russian consumer healthcare sector
STADA takes clear lead in Russian consumer healthcare sector

STADA has today closed a US$660 million transaction of a Russian brand portfolio from Takeda

Read more

03.03.2020
Dr. Stephan Eder is appointed as EVP of STADA Russia/CIS
Dr. Stephan Eder is appointed as EVP of STADA Russia/CIS

Stephan Eder decides to join STADA mid-year ss Executive Vice President of Russia-CIS

Read more

24.02.2020
STADA acquires 15 well-established GSK brands
STADA acquires 15 well-established GSK brands

STADA becomes a major Consumer Healthcare player

Read more